Unproven Stem Cell Interventions: A Global Public Health Problem Requiring Global Deliberation
Table of Contents
Author(s)
Kirstin R.W. Matthews
Fellow in Science and Technology PolicyZubin Master
Nonresident ScholarMohamed Abou-el-Enein
Executive Director, Joint USC/CHLA Cell Therapy Program, Keck School of MedicineShare this Publication
- Print This Publication
- Cite This Publication Copy Citation
Master Z, Matthews KRW, Abou-El-Enein M. Unproven stem cell interventions: A global public health problem requiring global deliberation. Stem Cell Reports. 2021 Jun 8;16(6):1435-1445. doi: 10.1016/j.stemcr.2021.05.004. PMID: 34107243; PMCID: PMC8190665.
The unproven stem cell intervention (SCI) industry is a global health problem. Despite efforts of some nations, the industry continues to flourish. In this paper, we call for a global approach and the establishment of a World Health Organization (WHO) Expert Advisory Committee on Regenerative Medicine to tackle this issue and provide guidance. The WHO committee can harmonize national regulations; promote regulatory approaches responsive to unmet patient needs; and formulate an education campaign against misinformation. Fostering an international dialog and developing recommendations that can be adopted by member states would effectively address the global market of unproven SCIs.
Read the full piece in Stem Cell Reports.